Back

Comprehensive Immunophenotyping of Monocytes and Dendritic Cells Suggests Distinct Pathophysiology in Chronic Fatigue Syndrome and Long COVID

Petrov, S. I.; Bozhkova, M.; Ivanovska, M.; Kalfova, T.; Dudova, D.; Todorova, Y.; Dimitrova, R.; Murdjeva, M.; Taskov, H.; Nikolova, M.; Maes, M.

2026-04-12 allergy and immunology
10.64898/2026.04.10.26350613 medRxiv
Show abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are complex chronic conditions that often follow infectious triggers with overlapping clinical features but poorly defined pathophysiological relationships. This study aimed to identify disease-specific immune signatures through multiparameter immunophenotyping of monocytes, dendritic cells, and T-cell subsets. A total of 207 participants were included (ME/CFS: n = 103; long COVID: n = 63; healthy controls: n = 41). Peripheral blood mononuclear cells were analyzed using multiparameter flow cytometry. Statistical analyses included non-parametric testing, age-adjusted ANCOVA, correlation network analysis, and principal component analysis (PCA). Long COVID was characterized by increased M2-like monocyte polarization, elevated CD80 expression across monocyte subsets, expansion of dendritic cells, and reduced expression of activation markers, indicating persistent immune activation with features of immune exhaustion. In contrast, ME/CFS exhibited reduced costimulatory molecule expression, impaired CCR7-mediated immune cell trafficking, and less coordinated activation patterns, consistent with a state of immune suppression. Correlation network analysis revealed more extensive and integrated immune interactions in long COVID, while PCA identified distinct immunophenotypic components and enabled moderate discrimination between the two conditions. These findings demonstrate that ME/CFS and long COVID are characterized by distinct immune profiles, supporting the concept of divergent immunopathological mechanisms. The identified signatures may contribute to biomarker development and guide targeted therapeutic approaches.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
586 papers in training set
Top 0.4%
12.6%
2
Journal of Translational Medicine
46 papers in training set
Top 0.1%
6.9%
3
Journal of Medical Virology
137 papers in training set
Top 0.3%
6.4%
4
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.2%
3.7%
5
Clinical Immunology
21 papers in training set
Top 0.1%
3.6%
6
Journal of Clinical Investigation
164 papers in training set
Top 1%
3.6%
7
Immunology
29 papers in training set
Top 0.2%
3.6%
8
eBioMedicine
130 papers in training set
Top 0.4%
3.1%
9
Scientific Reports
3102 papers in training set
Top 41%
3.1%
10
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.2%
2.6%
11
Life Science Alliance
263 papers in training set
Top 0.1%
2.4%
50% of probability mass above
12
Nature Communications
4913 papers in training set
Top 47%
2.1%
13
Allergy
23 papers in training set
Top 0.2%
2.1%
14
eLife
5422 papers in training set
Top 39%
1.8%
15
Frontiers in Plant Science
240 papers in training set
Top 4%
1.7%
16
PLOS ONE
4510 papers in training set
Top 53%
1.7%
17
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.7%
18
Pharmaceuticals
33 papers in training set
Top 0.9%
1.3%
19
Clinical and Experimental Immunology
12 papers in training set
Top 0.1%
1.3%
20
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 39%
1.1%
21
JCI Insight
241 papers in training set
Top 5%
1.0%
22
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.7%
1.0%
23
EMBO Reports
88 papers in training set
Top 0.4%
0.9%
24
ImmunoHorizons
21 papers in training set
Top 0.2%
0.9%
25
Journal of Clinical Immunology
11 papers in training set
Top 0.1%
0.9%
26
Cells
232 papers in training set
Top 5%
0.9%
27
Cell Reports Medicine
140 papers in training set
Top 6%
0.9%
28
Communications Biology
886 papers in training set
Top 21%
0.8%
29
The Lancet Rheumatology
11 papers in training set
Top 0.2%
0.8%
30
Frontiers in Neurology
91 papers in training set
Top 5%
0.8%